Meritage Portfolio Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,967
| Closed | -$203K | – | 346 |
|
|
2023
Q3 | $203K | Buy |
1,967
+25
| +1% | +$2.58K | 0.02% | 319 |
|
|
2023
Q2 | $236K | Buy |
1,942
+630
| +48% | +$76.6K | 0.02% | 317 |
|
|
2023
Q1 | $201K | Sell |
1,312
-32
| -2% | -$4.9K | 0.02% | 301 |
|
|
2022
Q4 | $241K | Buy |
+1,344
| New | +$241K | 0.02% | 285 |
|
|
2022
Q3 | – | Sell |
-1,576
| Closed | -$225K | – | 322 |
|
|
2022
Q2 | $225K | Hold |
1,576
| – | – | 0.02% | 279 |
|
|
2022
Q1 | $271K | Sell |
1,576
-35,670
| -96% | -$6.13M | 0.02% | 286 |
|
|
2021
Q4 | $9.46M | Buy |
37,246
+36,123
| +3,217% | +$9.17M | 0.54% | 47 |
|
|
2021
Q3 | $432K | Sell |
1,123
-23
| -2% | -$8.85K | 0.03% | 218 |
|
|
2021
Q2 | $269K | Sell |
1,146
-443
| -28% | -$104K | 0.02% | 262 |
|
|
2021
Q1 | $208K | Sell |
1,589
-3,365
| -68% | -$440K | 0.01% | 273 |
|
|
2020
Q4 | $518K | Buy |
+4,954
| New | +$518K | 0.04% | 205 |
|